R&D | March 20, 2026
NIPER Raebareli–Roche tie-up signals big push for India’s pharma innovation future
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
The first of four planned modules at the new plant is expected to come online by summer 2026
Designed for intense clinical environments, Rembra can handle up to 270 exams per day
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
The facility is dedicated to breakthrough innovations in laboratory instruments that detect infectious diseases, cancer, and blood disorders
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
The facility will bring 850 high-value jobs to the region, including engineers, scientists, operations personnel, and lab technicians
UK Prime Minister Keir Starmer praised the initiative, saying: “Unlocking opportunities for British businesses across the globe and delivering for working people back home is always the driving force behind my international engagements."
Treatment typically requires frequent injections directly into the eye—an ongoing burden for patients and health systems alike
Subscribe To Our Newsletter & Stay Updated
